Pharmacokinetic and pharmacodynamic evaluation of linagliptin in African American patients with type 2 diabetes mellitus

AIM: This was an open label, multicentre phase I trial to study the pharmacokinetics and pharmacodynamics of the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin in African American patients with type 2 diabetes mellitus (T2DM). METHODS: Forty-one African American patients with T2DM were include...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Friedrich, Christian, Glund, Stephan, Lionetti, Dominick, Kissling, C James, Righetti, Julian, Patel, Sanjay, Graefe-Mody, Ulrike, Retlich, Silke, Woerle, Hans-Juergen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Blackwell Science Inc 2013
Pynciau:
Pharmacokinetic Dynamic Relationships
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769671/
https://ncbi.nlm.nih.gov/pubmed/23331248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12077
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg